<DOC>
	<DOCNO>NCT00813774</DOCNO>
	<brief_summary>To compare bioavailability single dose certolizumab pegol solution give subcutaneously either one three formulation investigate safety tolerability .</brief_summary>
	<brief_title>Bio-availability Comparison Three Formulations Certolizumab Pegol Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Certolizumab Pegol</mesh_term>
	<criteria>Healthy male female volunteer age 18 55 Body Mass Index ( BMI ) 18 30 kg/m2 normal laboratory data negative Tuberculosis test normal Electrocardiogram ( ECG ) adequate contraception female give informed consent Any significant abnormality medical history , physical examination , laboratory test Intake concomitant medication smoke 10 cigarette per day alcohol drug abuse pregnancy breast feed history tuberculosis participation another trial within 3 month prior study previous administration certolizumab pegol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Cimzia</keyword>
	<keyword>certolizumab pegol</keyword>
	<keyword>Bioavailability</keyword>
	<keyword>Healthy volunteer</keyword>
</DOC>